首页> 外文期刊>Journal of cellular biochemistry. >Vascular smooth muscle cell-specific regulation of cyclin-dependent kinase inhibitor p21(WAF1/Cip1) transcription by Sp1 is mediated via distinct cis-acting positive and negative regulatory elements in the proximal p21(WAF1/Cip1) promoter.
【24h】

Vascular smooth muscle cell-specific regulation of cyclin-dependent kinase inhibitor p21(WAF1/Cip1) transcription by Sp1 is mediated via distinct cis-acting positive and negative regulatory elements in the proximal p21(WAF1/Cip1) promoter.

机译:Sp1介导细胞周期蛋白依赖性激酶抑制剂p21(WAF1 / Cip1)转录的血管平滑肌细胞特异性调节是通过近端p21(WAF1 / Cip1)启动子中独特的顺式作用正负调节因子介导的。

获取原文
获取原文并翻译 | 示例
           

摘要

Smooth muscle cells (SMC) play a central role in common vascular pathologies such as atherosclerosis and restenosis. Understanding the molecular regulation of SMC proliferation at a transcriptional level may provide important clues for the targeted control of vascular hyperplasia. We recently reported the capacity of the transcription factor Sp1 to down-regulate p21(WAF1/Cip1) production thereby reducing p21(WAF1/Cip1)-cyclin D1-Cdk4 complex formation and inhibiting vascular SMC proliferation (Kavurma and Khachigian [2003] J. Biol. Chem. 278, 32537-32543). We have now localized the Sp1-response elements in the p21(WAF1/Cip1) promoter responsible for p21(WAF1/Cip1) repression in WKY12-22 SMCs. The proximal region of the p21(WAF1/Cip1) promoter contains five distinct Sp1-binding elements that we have termed A, B, C, D, and E. Electrophoretic mobility shift analysis revealed that SMC nuclear Sp1 interacts with all five Sp1-binding sites, and each of these sites is critical for Sp1 repression of the p21(WAF1/Cip1) promoter, since mutation in any one element ablates repression, and in some cases results in activation. In contrast, only elements C, D, and E are bound by Sp1 in endothelial cells. Sp1 overexpression activates the p21(WAF1/Cip1) promoter in this cell type. Furthermore, mutation in any of these five elements is not sufficient to prevent activation of the p21(WAF1/Cip1) promoter by Sp1 in endothelial cells. Surprisingly, double mutations of elements C and E facilitates superactivation by Sp1 in both cell types, whereas triple mutations of C, D, and E inactivate the promoter. These findings demonstrate cell type-specific regulation of p21(WAF1/Cip1) transcription by Sp1 via distinct cis-acting positive and negative regulatory elements in the proximal p21(WAF1/Cip1) promoter.
机译:平滑肌细胞(SMC)在常见的血管病变(如动脉粥样硬化和再狭窄)中起着核心作用。在转录水平上了解SMC增殖的分子调控可为靶向控制血管增生提供重要线索。我们最近报道了转录因子Sp1下调p21(WAF1 / Cip1)产生的能力,从而减少p21(WAF1 / Cip1)-cyclin D1-Cdk4复合物的形成并抑制血管SMC增殖(Kavurma和Khachigian [2003]J。生物化学278,32537-32543)。现在,我们已将Sp1-响应元件定位在负责WKY12-22 SMC中p21(WAF1 / Cip1)抑制的p21(WAF1 / Cip1)启动子中。 p21(WAF1 / Cip1)启动子的近端区域包含五个不同的Sp1结合元件,我们将其称为A,B,C,D和E。电泳迁移率变化分析表明SMC核Sp1与所有五个Sp1结合相互作用个位点,这些位点中的每一个对于p21(WAF1 / Cip1)启动子的Sp1抑制都是至关重要的,因为任何一个元素的突变都会消除抑制,在某些情况下会导致激活。相反,在内皮细胞中,只有元素C,D和E被Sp1结合。 Sp1过表达激活这种细胞类型中的p21(WAF1 / Cip1)启动子。此外,这五个元素中任何一个的突变不足以阻止Sp1在内皮细胞中激活p21(WAF1 / Cip1)启动子。出乎意料的是,在两种细胞类型中,元素C和E的两次突变促进Sp1的超活化,而C,D和E的三次突变使启动子失活。这些发现表明Sp1通过近端p21(WAF1 / Cip1)启动子中不同的顺式作用正负调控元件对Sp21(WAF1 / Cip1)转录进行细胞类型特异性调控。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号